Pierre-Olivier Gourinchas

Pierre-Olivier Gourinchas grew up in France where he attended Ecole Polytechnique. He received his PhD in 1996 from MIT and taught at Stanford Graduate School of Business and Princeton University before joining the Berkeley economics department in 2003 as an assistant professor. He is a Research Associate with NBER and a Research Fellow with CEPR (London) and the International Growth Center (London).Professor Gourinchas is editor of the IMF Economic Review. He is also associate editor of the Journal of the European Economic Association and a member of the Scientific Committee of the Fondation Banque de France. He is the winner of the 2007 Bernacer Prize for best European Economist under 40 working in macroeconomics and finance, and winner of the 2008 prize for best French economist under 40.

This Is Not the Time to Be Cautious. We Need to Contain the Economic Contagion of the Coronavirus

The real danger is that the virus mutates and infects our economic system, even as we manage to root it out of our bodies....

Latest news

The Aristocracy of Talent: Business Intelligence

In the following excerpt from his new book, The Aristocracy of Talent: How Meritocracy Made the Modern World, Adrian Wooldridge traces "how universities...

Why Privacy Experts Need a Place at the Antitrust Table

Antitrust enforcers have tended to stay narrowly “in their lane,” failing to engage with how data is collected and used by digital...

Assessing George Stigler’s Economic Theory of Regulation

Despite its flaws and limitations, Stigler’s seminal article on the theory of economic regulation remains an important piece of scholarship worthy of...

“Old Chicago” and Freiburg: Why Ordoliberalism Was No “German Oddity”

Both the Chicago and Freiburg schools faced systemic fragility as the crucial property of societal orders. It was this fragility that served...

The Many Faces of Stigler’s Theory of Economic Regulation: Interest Group Politics Still Thrives—But Industry Often Comes Second

Stigler treats industry groups as the heavyweights in regulatory contests. But surprisingly often groups of farmers and workers knock them for a...

Why the FTC Should Consider Size in Drug Mergers

Large pharmaceutical firms retain their dominance through size-related advantages in three areas: contracting, marketing and selling, and financing. When reviewing pharmaceutical mergers,...

In FTC vs. Facebook, the Government Lost the First Round. It Could Still Win the Fight.

Despite some compelling allegations, a federal judge dismissed the FTC's antitrust complaint against Facebook due to the agency’s failure to explain how...